Intragastric balloon for treating obesity

US9795498B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9795498-B2
Application numberUS-201314433752-A
CountryUS
Kind codeB2
Filing dateOct 3, 2013
Priority dateOct 18, 2010
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.

First claim

Opening claim text (preview).

We claim: 1. An intragastric balloon configured to be implanted transorally into a patient's stomach to treat obesity, the intragastric balloon comprising: an inflatable, closed, hollow, compliant body including an outer shell having an inner wall surrounding and defining a closed inner chamber, the closed inner chamber having a volume that is substantially the same both before and after the closed inner chamber is filled with a fluid, wherein, in an implanted state, the closed inner chamber is filled partially with the fluids the body having a proximal end and a distal end opposite the proximal end, the shell being configured to retain the fluid in the closed inner chamber, wherein the body is made of a material that permits the body to be compressed into a substantially linear transoral delivery configuration, and that will resist degradation over a period of at least six months within the stomach, and wherein the closed inner chamber has one or more interconnected regions extending between the proximal and distal ends of the body, such that the fluid can flow freely within the closed inner chamber, the inflatable body filled with the fluid having a fluid volume that is less than the body volume, the body being constructed to conform to the shape of the stomach. 2. The intragastric balloon of claim 1 , wherein the fluid volume is between about 300 ml and about 700 ml. 3. The intragastric balloon of claim 2 , wherein the shell at the distal region has a greater thickness than the shell at the proximal region to prevent migration of the balloon out of the stomach. 4. The intragastric balloon of claim 2 , wherein the body includes a plurality of latitudinal ridges. 5. The intragastric balloon of claim 2 , wherein the body includes a plurality of longitudinal ridges. 6. The intragastric balloon of claim 2 , wherein the body includes a plurality of spaced pits. 7. The intragastric balloon of claim 1 , wherein the body has a plurality of regions including a proximal region and a distal region, and an outer wall of the shell of the body tapers from the proximal region to the distal region. 8. An intragastric balloon configured to be implanted transorally into a patient's stomach to treat obesity, the intragastric balloon comprising: an inflatable, closed, hollow, non-spherical body including a body shell, the body having a volume between about 300 mls and about 700 mls, which volume is substantially the same both before and after inflation of the body with a fluid, the fluid occupying less than the volume of the body, wherein the body shell is made of a compliant material and is permitted to be compressed into a substantially linear transoral delivery configuration, and that will resist degradation over a period of at least six months within the stomach, wherein the body has a single closed Internal chamber in which the fluid can flow freely, the inflatable body being under-inflated to conform to the shape of the stomach, wherein the body has a proximal region and a distal region, the proximal region larger than the distal region, the proximal region for inducing satiety by exerting a pressure on the stomach, and a smaller distal region for anchoring the balloon within the stomach, wherein the shell at one of the proximal region and the distal region is thicker than the body wall at the other of the proximal region and the distal region. 9. The intragastric balloon of claim 8 , wherein the shell of the distal region is thicker than the shell at the proximal region to prevent migration of the balloon out of the stomach. 10. The intragastric balloon of claim 8 , wherein the body tapers from the proximal region to the distal region. 11. The intragastric balloon of claim 8 , wherein the body is substantially conical in shape. 12. The intragastric balloon of claim 8 , wherein the shell includes a plurality of circumferential grooves. 13. The intragastric balloon of claim 8 , wherein the shell includes a plurality of latitudinal ridges. 14. The intragastric balloon of claim 8 , wherein the shell includes a plurality of longitudinal ridges.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9795498B2 cover?
A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.
Who is the assignee on this patent?
Apollo Endosurgery Inc, Apollo Endosurgery Us Inc
What technology area does this patent fall under?
Primary CPC classification A61F5/003. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).